Stacie M Goldberg

This inventor holds 18 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stacie M Goldberg. Retrieved from https://idiyas.com/inventor/stacie-m-goldberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 4)

% Patents Active = 94.4

CIPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 6.0

ph-index = 15

Forward Citations = 482(Granted Patents)

Location History:

Princeton, NJ (US) (2015)
Potomac, MD (US) (2018 - 2020)

Company Filing History:

18 out of 3,742

Bristol-Myers Squibb Compnay

patents

Years Active: 2015-2026

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12686716 - CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING (2026-07-21),

2. 12624107 - CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING (2026-05-12),

3. 12590154 - CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING (2026-03-31),

4. 10604575 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2020-03-31),

5. 10584170 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2020-03-10),

6. 10577423 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2020-03-03),

7. 10323093 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2019-06-18),

8. 10323092 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2019-06-18),

9. 10316091 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2019-06-11),

10. 10316090 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2019-06-11),

11. 10308714 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2019-06-04),

12. 10266596 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2019-04-23),

13. 10266595 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2019-04-23),

14. 10266594 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2019-04-23),

15. 10138299 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling (2018-11-27),

Title: The Innovative Journey of Stacie M Goldberg

Introduction: Stacie M Goldberg, a pioneering inventor based in Potomac, MD, has made significant contributions to the world of technology and innovation.

Latest Patents: Stacie M Goldberg's latest patents focus on advancements in renewable energy technologies, particularly in the field of solar power efficiency.

Career Highlights: With a background in engineering and a passion for sustainability, Stacie M Goldberg has led groundbreaking projects that have revolutionized the way we harness and utilize clean energy sources.

Collaborations: Throughout her career, Stacie M Goldberg has collaborated with leading research institutions and universities to further develop her innovative ideas and bring them to fruition.

Conclusion: Stacie M Goldberg's dedication to driving positive change through her inventive spirit continues to inspire and shape the future of sustainable technology.

Profile summary based on public USPTO records.